The expanding field of short-chain protein therapeutics represents a significant paradigm shift in how we approach disease and maximize athletic performance. Differing from traditional small molecules, peptides offer remarkable selectivity, often focusing on specific receptors or enzymes with unprecedented accuracy. This precise action minimizes of